Skip to main content

Advertisement

Table 4 Patient characteristics

From: Effectiveness of pharmaceutical support by pharmacists in urinary care teams

  Adoption n = 20   Non- adoption n = 8   p-value
Agea 85.5 (80.0–90.3) 80.5 (77.8–85.6) 0.328b
Sex (male/female) 11/9   2/6   0.221c
Primary disease
Femoral fracture 7   4  
Cerebrovascular disease 3   1   
Heart failure 1   1   
Orthopedics 1   1   
Pneumothorax 1   0   
Prostate cancer 1   0   
Cellulitis 1   0   
Endometriosis 1   0   
Pulmonary embolism 1   0   
Gastritis 1   0   
Heart stroke 1   0   
Fever of unknown origin 1   0   
Aspiration pneumonia 0   1   
Hospital stay duration (days)
Overalla 39.0 (30.0–47.3) 39.5 (31.0–48.6) 0.5001
After intervention of urinary care teama 22.5 (19.5–31.0) 22.0 (20.0–29.0) 0.636b
Score
Total score of urinary functiona 13.0 (9.5–14.0) 11.5 (10.0–13.3) 0.746b
Degree of independence of urinationa 8.0 (5.0–10.0) 7.0 (5.5–8.0) 0.381b
Score of lower urinary tract disordera 4.0 (3.0–5.0) 4.0 (4.0–6.3) 0.381b
Urinary situation
Intermittent urethral catheterization 17   6   0.391d
Urinary incontinence 1   0   
Use of nursing care diaper 1   2   
Continuous urethral catheter 1   0   
  1. aMedian (interquartile range; IQR)
  2. bMann-Whiteny U test
  3. cFisher Exact test
  4. dPearson χ2 test